2018 BIO International Convention - Triumvira Immunologics | Engineered T Cell Therapies
Triumvira President and Chief Executive Officer, Dr. Paul Lammers available for private meetings June 4-5
At BIO International, Triumvira Immunologics President and Chief Executive Officer, Dr. Paul Lammers will be available for private meetings during the day on June 4-5 to discuss potential collaboration and licensing opportunities for the Company’s novel immuno-oncology platform T Cell-Antigen Coupler (TAC).
[4th Annual Immuno-Oncology BD& ..](/content/4th-annual-immuno-oncology-bdl-and-investment-forum/ "4th Annual Immuno-Oncology BD&L and Investment Forum"/index.html) [Triumvira Expands Management T ..](/content/triumvira-expands-management-team-with-chief-medical-officer-and-vp-finance/ "Triumvira Expands Management Team with Chief Medical Officer and VP, Finance"/index.html)